Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Akcea Therapeutics
Akcea Therapeutics
(AKCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tegsedi
Inotersen
2018-10-05
2025-2031
Amyloidosis
,
Familial amyloid neuropathies
Waylivra
Volanesorsen
2019-05-03
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Volanesorsen
cardiovascular abnormalities
,
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemias
,
lipodystrophy
,
familial partial lipodystrophy
,
hypertriglyceridemia
Inotersen
amyloidosis
,
familial amyloid neuropathies
,
pregnancy
Pelacarsen
renal insufficiency
,
healthy volunteers/patients
,
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
VUPANORSEN
hypertriglyceridemia
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
lipodystrophy
,
familial partial lipodystrophy
,
liver diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
non-alcoholic fatty liver disease
,
fatty liver
,
hyperlipidemias
,
hyperlipoproteinemia type v
,
syndrome
,
hyperlipoproteinemia type i
,
hyperlipoproteinemias
,
homozygous familial hypercholesterolemia
Endocrine
healthy volunteers/patients
,
brain neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
thyroid neoplasms
,
papillary thyroid cancer
,
thyroid diseases
,
head and neck neoplasms
,
neoplasms by site
,
melanoma
,
sarcoma
,
fibrosarcoma
,
myofibromatosis
,
respiratory tract diseases
,
central nervous system neoplasms
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
colonic neoplasms
,
endocrine gland neoplasms
,
medullary carcinoma
,
bronchial neoplasms
,
ovarian neoplasms
,
endometrial neoplasms
,
squamous cell carcinoma of head and neck
,
uterine cervical neoplasms
,
breast diseases
,
hereditary sensory and autonomic neuropathies
,
obesity
,
type 2 diabetes mellitus
,
diabetes mellitus
,
endocrine system diseases
,
glucose metabolism disorders
,
metabolic diseases
,
male breast neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
breast neoplasms
,
neoplasm metastasis
,
neoplasms
,
triple negative breast neoplasms
,
type 1 diabetes mellitus
,
growth disorders
,
dwarfism
Trinessa
acinetobacter infections
Fluoroquinolone
healthy volunteers/patients
Thienopyridine
healthy volunteers/patients
,
blood platelet disorders
,
atherosclerosis
,
percutaneous coronary intervention
,
ischemia
,
intermittent claudication
,
thrombosis
,
congenital heart defects
,
atrial fibrillation
,
vascular diseases
,
unstable angina
,
arterial occlusive diseases
,
embolism
,
arteriosclerosis
,
st elevation myocardial infarction
,
stable angina
,
platelet aggregation
,
myocardial infarction
,
acute coronary syndrome
,
coronary artery disease
,
inferior wall myocardial infarction
,
infarction
,
peripheral arterial disease
,
myocardial ischemia
,
stroke
,
migraine disorders
,
atrial heart septal defects
,
metabolic syndrome
,
cerebral infarction
Tqj230
cardiovascular diseases
,
hyperlipidemias
,
hyperlipoproteinemias
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use